Physician profile
Nirav Hasmukh Amin
NPI 1477714665
$5,612,401.65
in general payments reported to CMS, 2019-2025
65 companies · $1.0M in 2025
The $1.0M reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $409K · 2020: $99K · 2021: $118K · 2022: $2.3M · 2023: $346K · 2024: $1.4M · 2025: $1.0M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $1.7M · Consulting Fee: $515K · Education: $191K · Travel and Lodging: $99K · Royalty Or License: $79K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $76K · Food and Beverage: $25K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $1,724,650.10 |
| Consulting Fee | $514,863.40 |
| Education | $190,923.50 |
| Travel and Lodging | $98,800.08 |
| Royalty Or License | $79,270.98 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $75,696.72 |
| Food and Beverage | $24,602.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $3,711,231.29 | 2022-2025 | Biobrace 23mm |
| Zimmer Biomet Holdings, INC. | $482,809.75 | 2019-2025 | Tapestry, Juggerknotless Soft Anchor, Comprehensive Shoulder System |
| Smith+Nephew, INC. | $450,274.82 | 2019-2025 | Microraptor, Real Intelligence, Coblation |
| Pacira Pharmaceuticals Incorporated | $347,000.95 | 2020-2025 | Iovera, Zilretta, Exparel |
| Trice Medical, INC. | $176,560.87 | 2019-2025 | |
| Medical Device Business Services, INC. | $96,804.95 | 2019-2024 | Rigidloop, Truespan Orthocord, Dynacord |
| Vertex Pharmaceuticals Incorporated | $84,156.87 | 2024-2025 | |
| Pacira Therapeutics, INC. | $68,462.19 | 2019-2020 | |
| Acelrx Pharmaceuticals, INC. | $34,514.28 | 2019-2021 | |
| Innocoll Pharmaceuticals Limited | $32,719.71 | 2022-2023 | Posimir, Xaracoll |
| Ossio INC | $32,216.05 | 2023-2024 | |
| Baudax Bio INC. | $30,119.94 | 2021-2022 | |
| Bioventus LLC | $21,852.09 | 2019-2023 | Agili-C |
| Depuy Synthes Products, INC. | $12,669.43 | 2019 | |
| US Implant Solutions, LLC | $9,637.51 | 2023-2025 |
Show all 65 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $6,902.76 | 2021-2025 | Zynrelef |
| Bone Support INC. | $3,165.00 | 2024-2025 | Cerament G, Ceramentbone Void Filler |
| Abanza INC. | $1,684.29 | 2025 | Washercap Mini Fixation System 4.5mm, Washercap Fixation System 10mm |
| Acumed LLC | $1,398.61 | 2020-2022 | |
| Pavmed INC. | $936.80 | 2021-2022 | |
| Stryker Corporation | $822.04 | 2019-2025 | Profyle, Variax, Gamma |
| Depuy Synthes Sales INC. | $657.01 | 2019-2024 | Truespan Orthocord, Dynacord, Milagro |
| Kci USA, INC. | $600.00 | 2019 | |
| Miach Orthopaedics, INC. | $574.71 | 2021-2025 | |
| Arcuro Medical INC | $569.60 | 2024-2025 | Superball, Superball |
| Anika Therapeutics, INC. | $569.42 | 2020-2025 | Integrity Implant, Tactoset |
| Biorez, INC. | $500.00 | 2022 | |
| Orpyx Medical Technologies INC. | $400.00 | 2021 | |
| Tenex Health INC. | $287.90 | 2021 | |
| Myoscience INC. | $220.62 | 2019 | |
| Curvafix, INC. | $196.55 | 2025 | Curvafix Im Implant |
| Davol INC. | $142.31 | 2020 | |
| Zurimed Technologies INC. | $135.81 | 2025 | Fiberlocker System |
| Globus Medical, INC. | $118.95 | 2023-2024 | Distal Femur Plate System, Distal Radius II |
| Allergan, INC. | $114.77 | 2019 | |
| Encore Medical, Lp | $110.67 | 2023 | Djo Surgical |
| Vericel Corporation | $101.03 | 2019 | |
| Electronic Waveform Lab, INC. | $81.59 | 2021-2022 | |
| Medtronic, INC. | $72.62 | 2023 | Intellis Adaptivestim, Mazor X System |
| Merz Pharmaceuticals, LLC | $66.17 | 2021-2023 | Xeomin |
| Vital Orthopedics LLC | $65.05 | 2025 | |
| Endeavor Orthopaedics LLC | $63.45 | 2025 | Summit Patella Plating System |
| Redhill Biopharma INC. | $62.94 | 2020-2021 | |
| Djo, LLC | $62.87 | 2020-2024 | Procare |
| Forte Bio-Pharma LLC | $61.71 | 2021 | |
| Ermi LLC | $59.20 | 2024 | |
| Tersera Therapeutics LLC | $58.86 | 2019-2020 | |
| Ibsa Pharma INC. | $54.09 | 2022-2024 | Tirosint, Licart, Tirosint |
| Next Science LLC | $52.75 | 2021-2023 | Xperience, Blastx, Surgx |
| Arthrex, INC. | $44.20 | 2023 | Shoulder Implants Fibertak Knotless |
| Avanos Medical | $35.30 | 2024-2025 | On-Q Pump and Accessories, Trivisc Sodium Hyaluronate |
| Saxum Surgical, INC. | $33.89 | 2025 | |
| Cartiheal (2009) Ltd. | $33.60 | 2023 | Agili-C |
| Abbvie INC. | $29.41 | 2024 | |
| Ethicon US, LLC | $28.28 | 2025 | Dermabond Prineo |
| Amgen INC. | $24.15 | 2024 | Prolia, Evenity |
| Radius Health, INC. | $22.99 | 2021 | |
| Merz North America, INC. | $22.62 | 2020 | |
| Lucid Diagnostics INC. | $22.52 | 2021 | |
| Hikma Pharmaceuticals USA | $22.00 | 2022 | |
| Eisai INC. | $18.80 | 2021 | |
| Scilex Pharmaceuticals INC. | $18.73 | 2020 | |
| Lilly USA, LLC | $15.21 | 2021 | |
| Sanofi-Aventis U.S. LLC | $14.58 | 2022 | |
| Glaxosmithkline, LLC. | $14.52 | 2024 | Shingrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$500.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$3,415,019.22 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nirav Amin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.